Table 3.

Factor loadings, VARIMAX rotation using a matched sample of 24,000 beneficiaries

No. of factors	One	Two		Three
Factor	1	1	2	1	2	3
(2.) Long-acting injectable	0.00	0.00	0.30	0.00	0.00	0.38
(3.) Clozapine use	0.08	0.00	0.24	0.02	0.00	0.33
(4., 5.) Adherence	0.12	0.07	0.25	0.11	0.05	0.29
(6.) No polypharmacy	0.00	0.00	0.00	0.00	0.00	0.00
(7.-9.) Follow-up after schizo. discharge	0.88	0.98	0.09	0.99	0.00	0.01
(10.-12.) Follow-up after MH ED visit	0.03	0.00	0.17	0.00	0.36	0.36
(14.) Quarterly ambulatory MH visits	0.24	0.09	0.99	0.23	0.00	0.86
(15.) No excessive schizo. acute care	0.92	0.91	0.10	0.83	0.56	0.00
(16.) No excessive MH acute care	0.87	0.87	0.08	0.75	0.65	0.00
(19., 20.) No re-admission after MH discharge	0.99	0.99	0.13	0.99	0.00	0.00
(21.) Psychosocial services	0.01	0.00	0.41	0.00	0.00	0.46
(23.) Psychotherapy	0.00	0.00	0.35	0.00	0.00	0.19
Cumulative % Variation	29	42			47
No. of parameters	30	46			53
AIC	255,243.5	258,851.1a			245,079.1
RMSEA	0.087	0.048			0.067
No. of factors	One	Two
Binary transformed indicators	1	1	2
(a.) Clozapine use	0.26	0.00	0.35
(b.) Adherence ≥80 %	0.32	0.12	0.38
(c.) Follow-up after schizo. discharge	0.66	0.59	0.34
(d.) Follow-up after MH ED visit	0.15	0.00	0.34
(e.) Quarterly ambulatory MH visits	0.38	0.13	0.93
(f.) No excessive schizo. acute care	0.90	0.88	0.01
(g.) No re-admission after MH discharge	0.94	1.00	0.00
(h.) Psychosocial services	0.13	0.00	0.42
Cumulative % Variation	31	46
No. of parameters	16	23
AIC	133,035.6	130,245.8
RMSEA	0.026	0.015

Note. Item 13 had no variation and was excluded. Item 22 was excluded and used as a validation measure. Loadings ≥ | 20 | considered meaningful. 0.00 items that were estimated as 0 by the model. ED=emergency department, MH=mental health, AIC=Aikaike Information Criteria, RMSEA=root mean squared error of approximation.

Bolded items are those with loadings at least | 0.20 |.

^aThe AIC is higher in the two factor model because some categories of items in the one factor models were combined.